Form 4: Aura Biosciences' Chief Technology Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Plavsic, Chief Technology Officer of Aura Biosciences, sold 2,151 shares of common stock at $7.75 to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On February 18, 2025, Mark Plavsic, the Chief Technology Officer of Aura Biosciences, Inc., sold 2,151 shares of the company's common stock.
- The shares were sold at a price of $7.75 per share.
- This transaction was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Plavsic directly owns 209,456 shares of Aura Biosciences.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes). It doesn't indicate positive or negative sentiment.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and employees.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of stock sale transaction by Mark Plavsic. |
Keywords
Aura Biosciences, AURA, Mark Plavsic, Chief Technology Officer, Form 4, SEC Filing, Stock Sale, Restricted Stock Units, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.